BioSpace News Archive

Reverie Labs , a pharmaceutical company pioneering the application of artificial intelligence in the discovery and development of next-generation kinase inhibitors, today announced a multi-target collab

Activ Surgical, a digital surgery pioneer, today announced that healthcare executive Paul Meister has been named to the company’s Board of Directors.

As Americans have the highest opioid use rates, leading to abuse,i the orthopaedic community has committed itself to studying prescription methods and patient populations to help mitigate potential addiction.

Cristillo to lead company’s Health Information Systems division and support services to health-focused missions

On July the 8 th , Croma-Pharma GmbH (Croma) has stated that the company submitted the drug file of its botulinum toxin product to the German authority BfArM. The filing of the dossier stands for the next essential step towards Croma’s complete aesthetic portfolio in Europe, which already comprises of a comprehensive HA filler range, threads, PRP and skincare products. Croma has licensed the product from the Ko

Cylera, the leading healthcare IoT (HIoT) cybersecurity and analytics company, announced today the company’s second annual virtual HIoT Summit 2020, which will take place from 10 a.m. ET - 5 p.m. ET on Tuesday, July 14, 2020.

Edgewise Therapeutics, a biopharmaceutical company developing small molecule therapies for musculoskeletal diseases, today announced the appointment of Abby H. Bronson to the newly created position of Vice President, Patient Advocacy and External Innovation. Ms. Bronson will be responsible f

Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) today announces the launch of NephU ( www.nephu.org ) (formerly PKDnetwork), a community and online resource library designed for healthcare professionals working in nephrology (study of the kidney) to help engage, collaborate, and share resources for people living with kidney disease. NephU offers its members access to a growing on-demand library

iPharma Labs, Inc. (“iPharma”), a privately-held contract development research organization (CDRO) specializing in inhalation pharmaceutical development services, announced today the addition of two new board members, expansion of the senior management/advisory team and the implementation of GMP testing services. These achievements have contributed to the continued successful growth of iPharma. Inhaled Covid-19 Treatments - Expanding G

John Krier Promoted to CEO Brian Baker Stepping Down for Personal Reasons, Continuing as Board Member and Consultant